β1-Adrenoreceptors regulate resting metabolic rate

Medicine and Science in Sports and Exercise

Volumn 29, Issue 6, 1997, Pages 769-774

  Lamont, Linda S ^a   Romito, Rochelle A ^b   Finkelhor, Robert S ^b   Kalhan, Satish C ^b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b NONE

Author keywords

Blockade; Atenolol; EPOC; Humans; Propranolol

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; PROPRANOLOL;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; NUTRITIONAL REQUIREMENT; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; CROSS-OVER STUDIES; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; OXYGEN CONSUMPTION; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030758145     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-199706000-00006     Document Type: Article

References (28)

1. ACHESON, K. J., E. RAVUSSIN, D. A. SCHOELLER, et al. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure. Metabolism 37:91-98 1988.
2. ANDERSSON, K. E. Drugs blocking adrenoceptors. Acta Med. Scand. (Suppl.) 665:9-17, 1982.
3. BAHR, R. Excess postexercise oxygen consumption: magnitude, mechanisms and practical implications. Acta Physiol. Scand. (Suppl.) 144:1-70, 1992.
4. BIELINSKI, R., Y. SCHULTZ, and E. JEQUIER. Energy metabolism during the postexercise recovery in man. Am. J. Clin. Nutr. 42: 69-82, 1985.
5. BORSHEIM, E., R. BAHR, P. HANSSON, L. GULLESTAD, J. HALLEN, and O. M. SEJERSTED. Effect of β-adrenoreceptor blockade on post-exercise oxygen consumption. Metabolism 43:565-571, 1994 .
6. BREHM, B. A. and B. GUTIN. Recovery energy expenditure for steady state exercise in runners and nonexercisers. Med. Sci. Sports Exerc. 18:205-210, 1986.
7. 2 uptake in trained and untrained women. J. Appl. Physiol. 70:1713-1719, 1991.
8. CHRISTIN, L., E. RAVUSSIN, C. BOGARDUS, and B. V. HOWARD. The effects of propranolol on free fatty acid mobilization and resting metabolic rate. Metabolism 38:439-444, 1989.
9. GAESSER, G. A. and G. A. BROOKS. Metabolic bases of excess post-exercise oxygen consumption: a review. Med. Sci. Sports Exerc. 16:29-43, 1984.
10. GALBO, H., J. J. HOST, and N. J. CHRISTENSON. Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J. Appl. Physiol. 40:855-863, 1976.
11. 2 during recovery. Med. Sci. Sports Exerc. 14:471-476, 1982.
12. 2. J. Appl. Physiol. 48:540-544, 1980.
13. HILL, A. V., C. N. H. LONG, and H. LUPTON. Muscular exercise, lactic acid and the supply and utilization of oxygen. Pt. I-III. Proc. Roy. Soc. B 96:438-475, 1924.
14. HIRSCH, H., R. L. LEIBEL, and N. K. EDENS. Overview: cellular corollaries of energy expenditure. In: Energy Metabolism: Tissue Determinants and Cellular Corollaries, J. M. Kinney and H. N. Tucker (Eds.). New York: Raven Press, 1992, pp. 525-532.
15. KAISER, P., P. A. TESCH, M. FRISK-HOLMBERG, A. JUHLIN-DANNFELT, and L. KAIJER. Effect of beta-1-selective and non-selective beta-blockade on work capacity and muscle metabolism. Clin. Physiol. 6:197-207, 1986.
16. LAMONT, L. S., D. G. PATEL, and S. C. KALHAN. β-adrenergic blockade alters whole-body leucine metabolism in humans. J. Appl. Physiol 67:221-225, 1989.
17. LAMONT, L. S., A. J. MCCULLOUGH, and S. C. KALHAN. β-adrenergic blockade heightens the exercise induced increase in leucine oxidation. Am. J. Physiol 268:(Endocrinol. Metab. 31): E910-E916, 1995.
18. LAURELL, S. and G. TEBBLING. Colorimetric microdetermination of free fatty acids in plasma. Clin. Chim. Acta 16:57-62 1967.
19. LUNDBORG, P., H. ASTROM, C. BENGTSSON, et al. Effect of beta-adrenoreceptor blockade on exercise performance and metabolism. Clin. Sci. 61:299-305, 1981.
20. NEWSHOLME, E. Substrate cycles: their metabolic, energetic and thermic consequences in man. Biochem. Soc. Symp. 43:183-205,1978.
21. QUINN, T. J., N. B. VROMAN, and R. KERTZER. Postexercise oxygen consumption in trained females: effect of exercise duration. Med. Sci. Sports Exerc. 26:908-913, 1994.
22. ROSSNER, S., C. L. TAYLOR, R. P. BYINGTON, et al. Long term propranolol treatment and changes in body weight after myocardial infarction. Br. Med. J. 300:902-903, 1990.
23. RUECKER, P. A., P. R. SLANE, and P. HANSON. Adding β-2 agonism does not improve β-1 blockade exercise responses in hypertensives. Med. Sci. Sports Exerc. 26:945-950, 1994.
24. SCHEIDEGGER, K., M. O'CONNELL, D. C. ROBBINS, and E. DANFORTH. Effects of chronic β-receptor stimulation on sympathetic nervous system activity, energy expenditure, and thyroid hormones. J. Clin. Endocrinol. Metab. 58:895-903, 1984.
25. 1-selective and a non-selective beta blocker. Eur. J. Appl. Physiol. 56:712-718, 1987.
26. WEIR, J. B. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. (Lond.) 109: 1-9, 1949.
27. WELLE, S. and K. S. NAIR. Relationship of resting metabolic rate to body composition and protein turnover. Am. J. Physiol. 258: E990-E998, 1990.
28. WELLE, S., R. G. SCHWARTZ, and M. STATT. Reduced metabolic rate during β-adrenergic blockade in humans. Metabolism 40:619-622, 1991.